All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0837 | Anti-GCLC (CBFYH-0290) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0290 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0838 | Anti-GCLC (CBFYH-0291) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0291 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4090 | Anti-GCLC (CBFYH-0290) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0290 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4091 | Anti-GCLC (CBFYH-0291) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0291 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1095 | Anti-GCLC (CBLG1-2680) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2680 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1096 | Anti-GCLC (CBLG1-2681) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat, Human | CBLG1-2681 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1097 | Anti-GCLC (CBLG1-805) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat, Human | CBLG1-805 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2735 | Anti-GCLC(CBLG1-2680) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2680 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2736 | Anti-GCLC(CBLG1-2681) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat, Human | CBLG1-2681 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2737 | Anti-GCLC(CBLG1-805) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat, Human | CBLG1-805 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION